Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Nature Communications
|
March 14, 2015
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic
Sharon W Way, Joseph R Podojil, Benjamin L Clayton, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 2018
B7-H4 Modulates Regulatory CD4<sup>+</sup> T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex
Joseph R Podojil, Ming-Yi Chiang, Igal Ifergan, et al.
Frontiers in Oncology
|
December 8, 2022
Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions
Ravi M Raghani, Jeffrey A Ma, Yining Zhang, et al.
NPJ Regenerative Medicine
|
December 5, 2024
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Ummiye V Onay, Dan Xu, Dauren Biyashev, et al.
Oncoimmunology
|
May 5, 2020
Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma
Joseph R Podojil, Alexander P Glaser, Dylan Baker, et al.
Journal of Cancer
|
April 11, 2022
ONP-302 Nanoparticles Inhibit Tumor Growth By Altering Tumor-Associated Macrophages And Cancer-Associated Fibroblasts
Laxminarasimha Donthireddy, Prashanthi Vonteddu, Tushar Murthy, et al.
The Journal of Experimental Medicine
|
March 1, 2018
Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy
Dan Xu, Andrew P Robinson, Toshiyuki Ishii, et al.
Gastroenterology
|
March 16, 2021
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciarán P Kelly, Joseph A Murray, Daniel A Leffler, et al.
Science Advances
|
October 5, 2022
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma
Andrea Piunti, Khyati Meghani, Yanni Yu, et al.
Science Advances
|
January 2, 2026
STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+ T cell tolerance
Joseph R Podojil, Andrew C Cogswell, Tobias Neef, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Nature Communications
|
March 14, 2015
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic
Sharon W Way, Joseph R Podojil, Benjamin L Clayton, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 2018
B7-H4 Modulates Regulatory CD4<sup>+</sup> T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex
Joseph R Podojil, Ming-Yi Chiang, Igal Ifergan, et al.
Frontiers in Oncology
|
December 8, 2022
Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions
Ravi M Raghani, Jeffrey A Ma, Yining Zhang, et al.
NPJ Regenerative Medicine
|
December 5, 2024
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Ummiye V Onay, Dan Xu, Dauren Biyashev, et al.
Oncoimmunology
|
May 5, 2020
Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma
Joseph R Podojil, Alexander P Glaser, Dylan Baker, et al.
Journal of Cancer
|
April 11, 2022
ONP-302 Nanoparticles Inhibit Tumor Growth By Altering Tumor-Associated Macrophages And Cancer-Associated Fibroblasts
Laxminarasimha Donthireddy, Prashanthi Vonteddu, Tushar Murthy, et al.
The Journal of Experimental Medicine
|
March 1, 2018
Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy
Dan Xu, Andrew P Robinson, Toshiyuki Ishii, et al.
Gastroenterology
|
March 16, 2021
TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Ciarán P Kelly, Joseph A Murray, Daniel A Leffler, et al.
Science Advances
|
October 5, 2022
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma
Andrea Piunti, Khyati Meghani, Yanni Yu, et al.
Science Advances
|
January 2, 2026
STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+ T cell tolerance
Joseph R Podojil, Andrew C Cogswell, Tobias Neef, et al.
Page
of 6